Journal
New England Journal of Medicine
Publication Date
9-19-2024
Volume
391
Issue
11
First Page
1002
Last Page
1014
Document Type
Open Access Publication
DOI
10.1056/NEJMoa2401537
Rights and Permissions
Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators. Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease. N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537. Copyright © 2024 Massachusetts Medical Society. Reprinted with permission.
Recommended Citation
Wolff, Daniel; Pusic, Iskra; and et al., "Axatilimab in recurrent or refractory chronic graft-versus-host disease." New England Journal of Medicine. 391, 11. 1002 - 1014. (2024).
https://digitalcommons.wustl.edu/oa_4/4914
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
